Literature DB >> 9851613

Stage-specific activity of the Leishmania major CRK3 kinase and functional rescue of a Schizosaccharomyces pombe cdc2 mutant.

Y Wang1, K Dimitrov, L K Garrity, S Sazer, S M Beverley.   

Abstract

Cell cycle control by cdc2-related kinases (CRKs) is essential to the regulation of cell proliferation and developmental processes in many organisms. Alternating phases of growth, arrest, and differentiation are characteristics of the infectious cycle of many trypanosomatid parasites, raising the possibility that members of the trypanosomatid CRK gene family participate in the regulation of these essential processes. Here we describe properties of the CRK3 gene from Leishmania major, which encodes a 36 kDa protein kinase showing 60% amino acid sequence identity with human CDK2, including several conserved sites implicated in regulation of kinase activity. CRK3 mRNA was constitutively expressed throughout the parasite life cycle, but histone H1 kinase activity of an epitope tagged CRK3 protein was greater in log-phase than in stationary-phase promastigotes. When integrated into the genome and expressed at the optimal level, CRK3 was able to rescue the growth defect of a Schizosaccharomyces pombe cdc2 mutant (cdc2-33(ts)), indicating that CRK3 is a functional homolog of cdc2. Mutants of CRK3 at several key regulatory residues showed the expected dominant negative effects on the S. pombe mutant. This is the first example of functional expression of a trypanosomatid CRK in yeast, opening the way for further genetic studies within this amenable organism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851613     DOI: 10.1016/s0166-6851(98)00121-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  11 in total

1.  Recombinant Leishmania mexicana CRK3:CYCA has protein kinase activity in the absence of phosphorylation on the T-loop residue Thr178.

Authors:  Felipe C Gomes; Nahla Osman M Ali; Elaine Brown; Roderick G Walker; Karen M Grant; Jeremy C Mottram
Journal:  Mol Biochem Parasitol       Date:  2010-03-23       Impact factor: 1.759

2.  Pairwise knockdowns of cdc2-related kinases (CRKs) in Trypanosoma brucei identified the CRKs for G1/S and G2/M transitions and demonstrated distinctive cytokinetic regulations between two developmental stages of the organism.

Authors:  Xiaoming Tu; Ching C Wang
Journal:  Eukaryot Cell       Date:  2005-04

Review 3.  Protein kinases as drug targets in trypanosomes and Leishmania.

Authors:  Christina Naula; Marilyn Parsons; Jeremy C Mottram
Journal:  Biochim Biophys Acta       Date:  2005-09-08

4.  In vitro activities of two antimitotic compounds, pancratistatin and 7-deoxynarciclasine, against Encephalitozoon intestinalis, a microsporidium causing infections in humans.

Authors:  M Ouarzane-Amara; J F Franetich; D Mazier; G R Pettit; L Meijer; C Doerig; I Desportes-Livage
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

5.  Rapid block of pre-mRNA splicing by chemical inhibition of analog-sensitive CRK9 in Trypanosoma brucei.

Authors:  Ujwala Gosavi; Ankita Srivastava; Nitika Badjatia; Arthur Günzl
Journal:  Mol Microbiol       Date:  2020-03-04       Impact factor: 3.501

6.  Inhibitors of Leishmania mexicana CRK3 cyclin-dependent kinase: chemical library screen and antileishmanial activity.

Authors:  Karen M Grant; Morag H Dunion; Vanessa Yardley; Alexios-Leandros Skaltsounis; Doris Marko; Gerhard Eisenbrand; Simon L Croft; Laurent Meijer; Jeremy C Mottram
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

7.  CDKA and CDKB kinases from Chlamydomonas reinhardtii are able to complement cdc28 temperature-sensitive mutants of Saccharomyces cerevisiae.

Authors:  M Cízková; A Pichová; M Vítová; M Hlavová; J Hendrychová; D Umysová; E Gálová; A Sevcovicová; V Zachleder; J G Umen; K Bisová
Journal:  Protoplasma       Date:  2008       Impact factor: 3.356

8.  High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.

Authors:  Roderick G Walker; Graeme Thomson; Kirk Malone; Matthew W Nowicki; Elaine Brown; David G Blake; Nicholas J Turner; Malcolm D Walkinshaw; Karen M Grant; Jeremy C Mottram
Journal:  PLoS Negl Trop Dis       Date:  2011-04-05

9.  Conditional gene deletion with DiCre demonstrates an essential role for CRK3 in Leishmania mexicana cell cycle regulation.

Authors:  Samuel M Duncan; Elmarie Myburgh; Cintia Philipon; Elaine Brown; Markus Meissner; James Brewer; Jeremy C Mottram
Journal:  Mol Microbiol       Date:  2016-04-13       Impact factor: 3.501

10.  Cyclin-Dependent Kinase CRK9, Required for Spliced Leader trans Splicing of Pre-mRNA in Trypanosomes, Functions in a Complex with a New L-Type Cyclin and a Kinetoplastid-Specific Protein.

Authors:  Nitika Badjatia; Sung Hee Park; Daniela L Ambrósio; Justin K Kirkham; Arthur Günzl
Journal:  PLoS Pathog       Date:  2016-03-08       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.